1-2 of 2
Bing Zheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia

Bing Zheng, Shang-Fan Yu, Geoffrey del Rosario, Steven R. Leong, Genee Y. Lee, Rajesh Vij, Cecilia Chiu, Wei-Ching Liang, Yan Wu, Cecile Chalouni, Jack Sadowsky, Vanessa Clark, Angela Hendricks, Kirsten Achilles Poon, Wayne Chu, Thomas Pillow, Melissa M. Schutten, John Flygare, Andrew G. Polson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (4): 1358–1368.
https://doi.org/10.1158/1078-0432.CCR-18-0333
Published: 15 February 2019
View article titled, An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia
Open the PDF for An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs

Shang-Fan Yu, Bing Zheng, MaryAnn Go, Jeff Lau, Susan Spencer, Helga Raab, Robert Soriano, Suchit Jhunjhunwala, Robert Cohen, Michele Caruso, Paul Polakis, John Flygare, Andrew G. Polson
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3298–3306.
https://doi.org/10.1158/1078-0432.CCR-14-2035
Published: 14 July 2015
View article titled, A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs
Open the PDF for A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs in another window
Includes: Supplementary data